By Professor Susan Jane Connor

Journal articles

Connor S, 2018, 'What can Australian Inflammatory Bowel Disease Association achieve in the next 3 to 5 years?', Journal of Gastroenterology and Hepatology (Australia), 33, pp. 35, http://dx.doi.org/10.1111/jgh.14437

Paramsothy S; Kamm M; Nielsen S; Deshpande N; Faith J; Clemente J; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong R; Connor S; Ng W; Lin E; Wilkins M; Colombel J-F; Borody T; Mitchell H; Kaakoush N, 2018, 'OP019 In faecal microbiota transplantation (FMT) for ulcerative colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short-chain fatty acid production are associated with remission (FOCUS study)', Journal of Crohn's and Colitis, 12, pp. S013 - S014, http://dx.doi.org/10.1093/ecco-jcc/jjx180.018

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor S; Radford-Smith G; Andrews J, 2018, 'P328 Crohn’s colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD)', Journal of Crohn's and Colitis, 12, pp. S266 - S268, http://dx.doi.org/10.1093/ecco-jcc/jjx180.455

Little R; Chu I; van der Zanden E; Flanagan E; Bell S; Sparrow M; Shelton E; Connor S; Roblin X; Ward M, 2018, 'P709 Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis', Journal of Crohn's and Colitis, 12, pp. S469 - S470, http://dx.doi.org/10.1093/ecco-jcc/jjx180.836

Paramsothy S; Kamm MA; Nielsen S; Deshpande N; Faith J; Clemente JC; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong RW; Connor SJ; Ng WSW; Lin E; Wilkins M; Colombel JF; Borody TJ; Mitchell HM; Kaakoush NO, 2018, '130 - In Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis, Fusobacterium is Associated with Lack of Remission, while Metabolic Shifts to Starch Degradation and Short Chain Fatty Acid Production are Associated with Remission – Results from the Randomized Controlled Focus Study', Gastroenterology, 154, pp. S - 35, http://dx.doi.org/10.1016/s0016-5085(18)30588-2

Little RD; Chu IE; van der Zanden E; Flanagan E; Bell S; Sparrow M; Shelton E; Connor SJ; Roblin X; Ward MG, 2018, 'Mo1883 - Is There a Difference in Adalimumab Drug Levels According to Pen vs. Syringe use - An International, Multicenter Retrospective Analysis', Gastroenterology, 154, http://dx.doi.org/10.1016/s0016-5085(18)32847-6

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor SJ; Radford-Smith GL; Andrews JM, 2018, 'Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD)', Gastroenterology, 154, pp. S - 892, http://dx.doi.org/10.1016/s0016-5085(18)33012-9

Lord A; Mortlock S; Montgomery G; Simms L; Krishnaprasad K; Hanigan K; Doecke JD; Gearry R; Lawrance I; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow M; Bell S; Walsh A; Radford-Smith GL, 2018, 'Tu1807 - Genetically Distinct Signatures of Mild and Severe Ulcerative Colitis', Gastroenterology, 154, pp. S - 1025, http://dx.doi.org/10.1016/s0016-5085(18)33433-4

Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW, 2017, 'Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases', Alimentary Pharmacology and Therapeutics, 46, pp. 1037 - 1053, http://dx.doi.org/10.1111/apt.14368

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011

Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ, 2017, 'The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus', Internal Medicine Journal, 47, pp. 1263 - 1269, http://dx.doi.org/10.1111/imj.13488

Chen GB; Lee SH; Montgomery GW; Wray NR; Visscher PM; Gearry RB; Lawrance IC; Andrews JM; Bampton P; Mahy G; Bell S; Walsh A; Connor S; Sparrow M; Bowdler LM; Simms LA; Krishnaprasad K; Radford-Smith GL; Moser G, 2017, 'Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method', BMC Medical Genetics, 18, pp. 94, http://dx.doi.org/10.1186/s12881-017-0451-2

Lawrance IC; Baird A; Lightower D; Radford-Smith G; Andrews JM; Connor S, 2017, 'Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis', Clinical Gastroenterology and Hepatology, 15, pp. 1248 - 1255, http://dx.doi.org/10.1016/j.cgh.2017.02.027

Toong CML; Lee MWM; Connor S; Ng W, 2017, 'Response to: Comparison of infliximab drug measurement across three commercially available ELISA kits: author reply', Pathology, 49, pp. 334 - 335, http://dx.doi.org/10.1016/j.pathol.2017.01.005

Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ, 2017, 'Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial', The Lancet, 389, pp. 1218 - 1228, http://dx.doi.org/10.1016/S0140-6736(17)30182-4

Doecke JD; Hartnell F; Bampton P; Bell S; Mahy G; Grover Z; Lewindon P; Jones LV; Sewell K; Krishnaprasad K; Prosser R; Marr D; Fischer J; R Thomas G; Tehan JV; Ding NS; Cooke SE; Moss K; Sechi A; De Cruz P; Grafton R; Connor SJ; Lawrance IC; Gearry RB; Andrews JM; Radford-Smith GL, 2017, 'Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study', Alimentary Pharmacology and Therapeutics, 45, pp. 542 - 552, http://dx.doi.org/10.1111/apt.13880

Lawrance IC; Baird A; Lightowler D; Radford-Smith G; Andrews JM; Connor S, 2017, 'OP007 A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis', Journal of Crohn's and Colitis, 11, pp. S4 - S5, http://dx.doi.org/10.1093/ecco-jcc/jjx002.006

Feagan BG; Sandborn WJ; Gasink C; Jacobstein D; Lang Y; Friedman JR; Blank MA; Johanns J; Gao LL; Miao Y; Adedokun OJ; Sands BE; Hanauer SB; Vermeire S; Targan S; Ghosh S; De Villiers WJ; Colombel JF; Tulassay Z; Seidler U; Salzberg BA; Desreumaux P; Lee SD; Loftus EV; Dieleman LA; Katz S; Rutgeerts P; Bampton P; Chung A; Connor S; Debinski H; Leong R; Macrae F; Pavli P; Sorrentino D; van den Bogaerde J; Vogel W; Vogelsang H; Louis E; Mana F; Zaltman C; Aumais G; Bernstein C; Bressler B; Dhalla S; Marshall J; Panaccione R; Ropeleski M; Stehlik J; Volfova M; Brynskov J; Glerup H; Abitbol-Selinger V; Allez M; Beaugerie L; Bourreille A; Cadiot G; Dupas J; Grimaud J; Laharie D; Lerebours E; Moreau J; Baumgart D; Brand S; Ebert M; Ehehalt R; Hasselblatt P; Howaldt S; Klaus J; Krummenerl P; Kucharzik T; Lügering A; Mudter J; Preiss J; Schreiber S; Stallmach A; Stein J; Strauch U; Salamon A; Patchett S; Lahat-Zok A; Rachmilewitz D; Annese V; Bossa F; Guidi L; Kohn A; Rocca R; Ando A; Ashida T; Hanai H; Ishida T; Ito H; Matsumoto T; Motoya S; Nakamura S; Sameshima Y; Suzuki Y; Watanabe K; Yamagami H; Yamamoto T, 2016, 'Ustekinumab as induction and maintenance therapy for Crohn's disease', New England Journal of Medicine, 375, pp. 1946 - 1960, http://dx.doi.org/10.1056/NEJMoa1602773

Stein J; Connor S; Virgin G; Ong DEH; Pereyra L, 2016, 'Anemia and iron deficiency in gastrointestinal and liver conditions', World Journal of Gastroenterology, 22, pp. 7908 - 7925, http://dx.doi.org/10.3748/wjg.v22.i35.7908

Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Hvas CL; Bibby BM; Uldbjerg N; Connell WR; Rosella O; Grosen A; Brown SJ; Kjeldsen J; Wildt S; Svenningsen L; Sparrow MP; Walsh A; Connor SJ; Radford-Smith G; Lawrance IC; Andrews JM; Ellard K; Bell SJ, 2016, 'Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection', Gastroenterology, 151, pp. 110 - 119, http://dx.doi.org/10.1053/j.gastro.2016.04.002

Chen JH; Andrews JM; Kariyawasam V; Moran N; Gounder P; Collins G; Walsh AJ; Connor S; Lee TWT; Koh CE; Chang J; Paramsothy S; Tattersall S; Lemberg DA; Radford-Smith G; Lawrance IC; McLachlan A; Moore GT; Corte C; Katelaris P; Leong RW, 2016, 'Review article: Acute severe ulcerative colitis - Evidence-based consensus statements', Alimentary Pharmacology and Therapeutics, 44, pp. 127 - 144, http://dx.doi.org/10.1111/apt.13670

Connor SJ, 2016, 'Biologic Therapeutic Drug Monitoring in Australia', Journal of Gastroenterology and Hepatology (Australia), 31, pp. 8 - 9, http://dx.doi.org/10.1111/jgh.13346

Elnawsra O; Fok I; Sparrow M; Gibson P; Andrews J; Connor S, 2016, 'Faecal calprotectin: Current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists', Internal Medicine Journal, 46, pp. 590 - 595, http://dx.doi.org/10.1111/imj.13056

Thompson KD; Connor SJ; Walls DM; Gollins J; Stewart SK; Bewtra M; Baumblatt GL; Holubar SD; Greenup AJ; Sechi A; Girgis A; Rubin DT; Siegel CA, 2016, 'Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications', Inflammatory Bowel Diseases, 22, pp. 940 - 947, http://dx.doi.org/10.1097/MIB.0000000000000740

Andrews JM; Costello SP; Agarwal AK; Bampton P; Beswick L; Connor S; Ghaly S; O'Connor S; Pudipeddi A; Sechi A; Sparrow M; Walsh AJ, 2016, 'Conflict of interest: Real and perceived - a more mature consideration is needed', Internal Medicine Journal, 46, pp. 377 - 379, http://dx.doi.org/10.1111/imj.12989

Sechi A; Sawyer E; Ng WSW; Connor SJ, 2016, 'Mo1089 Proving Cost Effectiveness Through Implementation of a Nurse-Led Inflammatory Bowel Disease (IBD) Patient Advice Line and Virtual Clinic (CHEAP)', Gastroenterology, 150, pp. S631 - S631, http://dx.doi.org/10.1016/s0016-5085(16)32166-7

Bye W; Sparrow M; Connor SJ; Andrews JM; Watson Ng WS; Ellard K; Hume G; Antoniades SA; Walsh A, 2016, 'Su1831 Identifying “At Risk” Inflammatory Bowel Disease Patients Who May Be Targeted With a New Adjuvanted Herpes Zoster Subunit Vaccine', Gastroenterology, 150, pp. S564 - S565, http://dx.doi.org/10.1016/s0016-5085(16)31930-8

Paramsothy S; Walsh AJ; Borody T; Samuel D; Van Den Bogaerde J; Leong RWL; Connor S; Ng W; Mitchell HM; Kaakoush NO; Kamm MA, 2015, 'Gastroenterologist perceptions of faecal microbiota transplantation', World Journal of Gastroenterology, 21, pp. 10907 - 10914, http://dx.doi.org/10.3748/wjg.v21.i38.10907

Ko Y; Kariyawasam V; Karnib M; Butcher R; Samuel D; Alrubaie A; Rahme N; McDonald C; Cowlishaw J; Katelaris P; Barr G; Jones B; Connor S; Paven G; Chapman G; Park G; Gearry R; Leong RW, 2015, 'Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia', Clinical Gastroenterology and Hepatology, 13, pp. 1453 - 1463.e1, http://dx.doi.org/10.1016/j.cgh.2015.02.045

Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P; Walsh AJ; Andrews JM, 2015, 'Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: The benefits to patients', Internal Medicine Journal, 45, pp. 659 - 666, http://dx.doi.org/10.1111/imj.12732

Paramsothy S; Borody TJ; Lin E; Finlayson S; Walsh AJ; Samuel D; Van Den Bogaerde J; Leong RWL; Connor S; Ng W; Mitchell HM; Kaakoush N; Kamm MA, 2015, 'Donor recruitment for fecal microbiota transplantation', Inflammatory Bowel Diseases, 21, pp. 1600 - 1606, http://dx.doi.org/10.1097/MIB.0000000000000405

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Antoniades S; Headon B; Connor S; Lawrance IC; Sparrow M; Walsh AJ; Andrews JM, 2015, 'Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response', Internal Medicine Journal, 45, pp. 170 - 177, http://dx.doi.org/10.1111/imj.12621

Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Kjeldsen J; Wildt S; Svenningsen L; Connell W; Hvas CL; Sparrow M; Walsh A; Connor SJ; Radford-Smith GL; Lawrance IC; Andrews JM; Ellard K; Rosella O; Grosen A; Santamaria JD; Bell S, 2015, '540 Adalimumab and Infliximab Levels in Neonates (ERA Study)', Gastroenterology, 148, pp. S - 108, http://dx.doi.org/10.1016/s0016-5085(15)30372-3

Chen J-H; Corte CJ; Kariyawasam VC; Moran N; Gounder P; Collins GD; Connor SJ; Lee T; Walsh A; Koh CE; Chang J; Paramsothy S; Tattersall SJ; Lemberg DA; McLachlan A; Moore GT; Andrews JM; Leong RW, 2015, 'Su1102 Consensus Statements on the Management of Acute Severe Ulcerative Colitis', Gastroenterology, 148, pp. S - 408, http://dx.doi.org/10.1016/s0016-5085(15)31373-1

Ooi S-YJ; Gounder M; Grafton R; Leach P; Bampton PA; Sechi A; Ng WSW; Connor SJ; Andrews JM, 2015, 'Tu1330 Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study', Gastroenterology, 148, pp. S - 861, http://dx.doi.org/10.1016/s0016-5085(15)32918-8

Ooi S-YJ; Gounder M; Grafton R; Leach P; Bampton PA; Sechi A; Ng WSW; Connor SJ; Andrews JM, 2015, 'Tu1331 Are We Under-Recognizing Skewed Thiopurine Metabolism in IBD Patients? Routine Thiopurine Metabolite Measurement Yields Clinical Benefit at 12 Months: A Retrospective Observational Study', Gastroenterology, 148, pp. S - 861, http://dx.doi.org/10.1016/s0016-5085(15)32919-x

Heap GA; Weedon MN; Bewshea CM; Singh A; Chen M; Satchwell JB; Vivian JP; So K; Dubois PC; Andrews JM; Annese V; Bampton P; Barnardo M; Bell S; Cole A; Connor SJ; Creed T; Cummings FR; D'Amato M; Daneshmend TK; Fedorak RN; Florin TH; Gaya DR; Greig E; Halfvarson J; Hart A; Irving PM; Jones G; Karban A; Lawrance IC; Lee JC; Lees C; Lev-Tzion R; Lindsay JO; Mansfield J; Mawdsley J; Mazhar Z; Parkes M; Parnell K; Orchard TR; Radford-Smith G; Russell RK; Reffitt D; Satsangi J; Silverberg MS; Sturniolo GC; Tremelling M; Tsianos EV; Van Heel DA; Walsh A; Watermeyer G; Weersma RK; Zeissig S; Rossjohn J; Holden AL; Ahmad T, 2014, 'HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants', Nature Genetics, 46, pp. 1131 - 1134, http://dx.doi.org/10.1038/ng.3093

Julsgaard M; Christensen LA; Fallingborg J; Gearry R; Radford-Smith G; Walsh A; Kjeldsen J; Sparrow MP; Andrews JM; Connor SJ; Lawrence I; Gibson PR; Rosella O; Grosen A; Bell SJ, 2014, 'Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth', JOURNAL OF CROHNS & COLITIS, 8, pp. S34 - S35, http://dx.doi.org/10.1016/S1873-9946(14)60066-0

Julsgaard M; Christensen LA; Lawrence I; Gearry R; Connell W; Grosen A; Svenningsen L; Andrews JM; Bampton P; Walsh A; Moore GT; Radford-Smith G; Brown S; Hvas CL; Kjeldsen J; Connor SJ; Sparrow MP; Fallingborg J; Bell SJ, 2014, 'Pregnancy outcome and counselling of anti-TNF-alpha treated IBD women: an ongoing international multicentre study', JOURNAL OF CROHNS & COLITIS, 8, pp. S222 - S223, http://dx.doi.org/10.1016/S1873-9946(14)60497-9

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Headon B; Prosser R; Connor S; Lawrance IC; Sparrow M; Bampton P; Walsh A; Andrews J, 2014, 'Short term dose tailoring of anti TNF-alpha therapy delivers useful clinical efficacy in Crohn's disease patients with secondary loss of response', JOURNAL OF CROHNS & COLITIS, 8, pp. S209 - S209, http://dx.doi.org/10.1016/S1873-9946(14)60466-9

Sze KCP; Ng WSW; Connor SJ, 2014, 'Thiopurine metabolite monitoring and allopurinol combination therapy: current utilisation and influence on Australian gastroenterology IBD practice', JOURNAL OF CROHNS & COLITIS, 8, pp. S194 - S194, http://dx.doi.org/10.1016/S1873-9946(14)60432-3

Hussain MI; Hall BM; Depczynski B; Connor SJ, 2014, 'Acute renal failure and metformin-associated lactic acidosis following colonoscopy', Diabetes Research and Clinical Practice, 105, http://dx.doi.org/10.1016/j.diabres.2013.12.055

Ko Y; Karnib M; Samuels D; Alrubaie A; Rahme N; McDonald C; Katelaris P; Barr G; Jones B; Paven G; Chapman G; Park G; Meredith C; Connor S; Gearry R; Leong RWL, 2014, 'Environmental Risk Factors for Inflammatory Bowel Disease: A Case-Control Study in a Middle Eastern Migrant Population', Clinical Gastroenterology and Hepatology, 12, pp. 160 - 161, http://dx.doi.org/10.1016/j.cgh.2013.09.041

Siegel CA; Thompson KD; Walls D; Connor SJ; Stewart SK; Bewtra M; Rubin DT; Baumblatt GL; Holubar SD; Greenup A-J; Sechi A; Girgis A; Gollins J, 2014, 'Sa1122 Patients With Ulcerative Colitis Are More Concerned About Complications of Their Disease Than Side Effects of Medications', Gastroenterology, 146, pp. S - 205, http://dx.doi.org/10.1016/s0016-5085(14)60726-5

Thompson KD; Connor SJ; Walls D; Gollins J; Stewart SK; Bewtra M; Baumblatt GL; Holubar SD; Greenup A-J; Sechi A; Girgis A; Rubin DT; Siegel CA, 2014, 'Sa1123 What Patients Want to Know When Making Decisions About Their Treatment for Ulcerative Colitis: A Mixed Methods Approach Using Affect Trace Technology', Gastroenterology, 146, http://dx.doi.org/10.1016/s0016-5085(14)60727-7

Sze KC; Siriwardana A; Sechi A; Watson Ng WS; Connor SJ, 2014, 'Sa1272 Thiopurine Prescribing and Monitoring Behavior, Including Metabolites Testing and Allopurinol Co-Therapy: An Australian Perspective From 2008 to 2013', Gastroenterology, 146, pp. S - 249, http://dx.doi.org/10.1016/s0016-5085(14)60876-3

Walsh A; Weltman MD; Burger DM; Vivekanandarajah S; Connor S; Howlett M; Radford-Smith G; Selby W; Veillard A; Grimm M; Travis S; Lawrence IC, 2013, 'Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease', Journal of Crohn's and Colitis, http://dx.doi.org/10.1016/j.crohns.2013.02.019

Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC, 2012, 'Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD', MOLECULAR BIOSYSTEMS, 8, pp. 3125 - 3133, http://dx.doi.org/10.1039/c2mb25194a

Koo JH; You B; Liu K; Athureliya MD; Tang CWY; Redmond D; Connor S; Leong R, 2012, 'Colorectal cancer screening practice is influenced by ethnicity of medical practitioner and patient', Journal of Gastroenterology and Hepatology, 27, pp. 390 - 396

Fok K; Ng WW; Henderson CJ; Connor S, 2012, 'Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab', Journal of Crohn's and Colitis, 2012, pp. 708 - 712, http://dx.doi.org/10.1016/j.crohns.2012.01.008

Back to profile page